NCT07121140View on ClinicalTrials.gov

Home Blood Transfusions

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 3, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Hematologic MalignancyMyelodysplastic SyndromesAcute Myeloid LeukemiaTransfusion Dependent Cytopenias
Interventions
PROCEDURE

Home Blood Transfusion

Participants will be provided with transfusion of blood products, specifically red blood cells and platelets, in the home setting.

Trial Locations (1)

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

Thomas Jefferson University

OTHER

NCT07121140 - Home Blood Transfusions | Biotech Hunter | Biotech Hunter